|
Improving Patient Outcomes via Novel Bispecific Antibody Treatment Options for B-cell Non-Hodgkin Lymphomas - Empowering Peer-to-Peer Education |
10/17/2025 - 8:00am to 9:00am EDT |
|
Autoimmune Hemolytic Anemia: From Pathophysiology to Clinical Management 2025 |
10/24/2025 - 8:00am to 9:00am EDT |
|
Targeting EGFR Alterations: Precision Approaches to Frontline Treatment of Late-Stage Non-Small Cell Lung Cancer (NSCLC) |
10/31/2025 - 8:00am to 9:00am EDT |
|
Navigating an Uncommon Diagnosis: Metastatic Chromophobe Renal Cell Carcinoma |
11/07/2025 - 8:00am to 9:00am EST |
|
Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers Molecular Testing and BRAF Inhibitors in Community Settings |
11/14/2025 - 8:00am to 9:00am EST |
|
Relapsed DLBCL in 2025: A Case-Based Update on Bispecifics, ADCs and CAR-T |
11/21/2025 - 8:00am to 9:00am EST |
|
Optimizing Multidisciplinary Approaches in the Guideline-Driven Management of Cervical and Endometrial Cancers |
12/12/2025 - 8:00am to 9:00am EST |
|
ASH 2025 Updates |
12/19/2025 - 8:00am to 9:00am EST |
|
A Case of Testicular Cancer with a Focus on Survivorship |
01/09/2026 - 8:00am to 9:00am EST |
|
Revealing New Sequences in CLL: Collaborative Care Planning With Real-World Evidence & Modern Therapeutics |
01/16/2026 - 8:00am to 9:00am EST |
Facebook
X
LinkedIn
Forward